Molina Healthcare Reports Solid Revenue Growth Amid Declining Profit Margins
Molina Healthcare (NYSE:MOH) reported impressive revenue growth in the fourth quarter of calendar year 2024, as the company's sales surged by 16% year-over-year, reaching $10.5 billion. According to Finance Yahoo, this figure exceeded Wall Street's expectations by 1.9%.
Despite the revenue success, Molina Healthcare experienced a setback in its profit margins. The company's GAAP profit per share stood at $4.44, falling short by 19% compared to analysts' consensus estimates. However, CEO Joseph Zubretsky remains optimistic, stating, "I am very pleased our 2024 revenue growth exceeded our long-term targets and we produced consolidated pre-tax margins within our long-term target range."
Founded in 1980, Molina Healthcare provides insurance primarily for those eligible for government-sponsored programs like Medicare and Medicaid. Over the last five years, the company has recorded a commendable annual sales growth rate of 19.3%, outperforming the healthcare industry average and indicating a strong market demand for its products and services. However, recent data shows a deceleration to an annualized revenue growth of 12.8% over two years, as per the data on the IndexBox platform.
As Molina Healthcare positions itself for future growth, analysts are forecasting a more modest 6.5% revenue increase over the next 12 months. With a current customer base of 5.5 million—an increase achieved at an average yearly growth of 4.3%—the company is seeing higher spending per customer on its insurance offerings.
Nevertheless, the pressing challenge for Molina continues to be its operating margins, which averaged a weak 4.2% over the past five years. The Q4 2024 operating profit margin was reported at 3.6%, aligning with the previous year's results, but signaling stability rather than growth. The company's earnings per share (EPS) grew at a 12.2% compounded annual rate over five years, yet lagged behind its revenue growth due to increased operational costs, taxes, and interest expenses.
Molina Healthcare's ability to manage its cost base and adapt to regulatory and economic changes remains critical as the healthcare industry faces potential reforms and technological shifts. Despite the shortfall in earnings, analysts anticipate a promising future, projecting a 19.4% EPS growth over the next year, potentially signalling strategic recalibrations. Following the Q4 earnings release, Molina Healthcare's stock experienced a notable dip of 9.2% to $288, reflecting investor concerns over short-term profitability.
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND THE AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional EditionPRO
3. MARKET OVERVIEW
Understanding the Current State of The Market and its Prospects
- MARKET SIZE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- CONSUMPTION BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET FORECAST TO 2035
4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION
Finding New Products to Diversify Your Business
- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCTS
- MOST TRADED PRODUCTS
- MOST PROFITABLE PRODUCTS FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Export
- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- PRODUCTION BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
-
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- United States
- China
- Japan
- Germany
- United Kingdom
- France
- Brazil
- Italy
- Russian Federation
- India
- Canada
- Australia
- Republic of Korea
- Spain
- Mexico
- Indonesia
- Netherlands
- Turkey
- Saudi Arabia
- Switzerland
- Sweden
- Nigeria
- Poland
- Belgium
- Argentina
- Norway
- Austria
- Thailand
- United Arab Emirates
- Colombia
- Denmark
- South Africa
- Malaysia
- Israel
- Singapore
- Egypt
- Philippines
- Finland
- Chile
- Ireland
- Pakistan
- Greece
- Portugal
- Kazakhstan
- Algeria
- Czech Republic
- Qatar
- Peru
- Romania
- Vietnam
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption, by Country, 2022–2024
- Production, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Import Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Export Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
LIST OF FIGURES
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Consumption, by Country, 2024
- Market Volume Forecast to 2035
- Market Value Forecast to 2035
- Market Size and Growth, By Product
- Average Per Capita Consumption, By Product
- Exports and Growth, By Product
- Export Prices and Growth, By Product
- Production Volume and Growth
- Exports and Growth
- Export Prices and Growth
- Market Size and Growth
- Per Capita Consumption
- Imports and Growth
- Import Prices
- Production, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Production, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Production, by Country, 2024
- Production, In Physical Terms, by Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Import Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Export Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)